BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3581059)

  • 21. SCH 51344 inhibits ras transformation by a novel mechanism.
    Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A
    Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoplastic transformation dose response of oncogene-transfected rat embryo cells by gamma rays or 6 MeV alpha particles.
    Ling CC; Weiss H; Strauss A; Endlich B; Sheh Y; Wei JX; Orazem J
    Radiat Res; 1994 Apr; 138(1):79-85. PubMed ID: 8146303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of the K-ras protooncogene in lung tumors from rats and mice chronically exposed to tetranitromethane.
    Stowers SJ; Glover PL; Reynolds SH; Boone LR; Maronpot RR; Anderson MW
    Cancer Res; 1987 Jun; 47(12):3212-9. PubMed ID: 3581065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional inhibition of Ha-ras in interferon-induced revertants of ras-transformed mouse cells.
    Rimoldi D; Samid D; Flessate DM; Friedman RM
    Cancer Res; 1988 Sep; 48(18):5157-62. PubMed ID: 2457435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ornithine decarboxylase gene expression is aberrantly regulated via the cAMP signal transduction pathway in malignant H-ras transformed cell lines.
    Hurta RA; Wright JA
    J Cell Physiol; 1994 Nov; 161(2):383-91. PubMed ID: 7525612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of transforming growth factor beta receptors in H-ras oncogene-transformed rat intestinal epithelial cells.
    Zhao J; Buick RN
    Cancer Res; 1995 Dec; 55(24):6181-8. PubMed ID: 8521411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preneoplastic potential of morphologically distinct transformed foci induced by 3-methylcholanthrene.
    Keshava N; Keshava C; Whong WZ; Hubbs AF; Nath J; Ong T
    Environ Mol Mutagen; 1998; 32(4):369-76. PubMed ID: 9882012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The product of the cph oncogene is a truncated, nucleotide-binding protein that enhances cellular survival to stress.
    Velasco JA; Avila MA; Notario V
    Oncogene; 1999 Jan; 18(3):689-701. PubMed ID: 9989819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotypic modulation of keratins, vimentin, and alpha-fetoprotein in cultured rat liver epithelial cells after chemical, oncogene, and spontaneous transformation.
    Bisgaard HC; Ton PT; Nagy P; Thorgeirsson SS
    J Cell Physiol; 1994 Jun; 159(3):485-94. PubMed ID: 7514612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
    Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
    Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased expression of the glucose-regulated gene encoding the Mr 78,000 glucose-regulated protein in chemically and radiation-transformed C3H 10T1/2 mouse embryo cells.
    Patierno SR; Tuscano JM; Kim KS; Landolph JR; Lee AS
    Cancer Res; 1987 Dec; 47(23):6220-4. PubMed ID: 2445468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transformation of NIH/3T3 to anchorage independence by H-ras is accompanied by loss of suppressor activity.
    Tolsma SS; Cohen JD; Ehrlich LS; Bouck NP
    Exp Cell Res; 1993 Apr; 205(2):232-9. PubMed ID: 8482334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ha-ras and v-raf oncogenes, but not int-2 and c-myc, interfere with the lactogenic hormone dependent activation of the mammary gland specific transcription factor.
    Happ B; Hynes NE; Groner B
    Cell Growth Differ; 1993 Jan; 4(1):9-15. PubMed ID: 8424907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell culture studies on the mechanism of action of chemical carcinogens and tumor promoters.
    Weinstein IB
    Carcinog Compr Surv; 1985; 10():177-87. PubMed ID: 4064003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
    Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
    Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
    Hollmann CA; Kittrell FS; Medina D; Butel JS
    Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transformation by H-ras can result in aberrant regulation of ornithine decarboxylase gene expression by transforming growth factor-beta(1).
    Hurta RA; Lee J; Voskas D
    J Cell Biochem; 2001; 81(1):39-55. PubMed ID: 11180396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. k-FGF protoncogene expression is associated with murine testicular teratogenesis, but is not involved during mouse testicular development.
    de Anta JM; Monzó M; Peris B; Ruano D
    Histol Histopathol; 1997 Jan; 12(1):33-41. PubMed ID: 9046041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
    Chen H; Liu J; Zhao CQ; Diwan BA; Merrick BA; Waalkes MP
    Toxicol Appl Pharmacol; 2001 Sep; 175(3):260-8. PubMed ID: 11559025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EGFR, ErbB2 and Ras but not Src suppress RhoB expression while ectopic expression of RhoB antagonizes oncogene-mediated transformation.
    Jiang K; Delarue FL; Sebti SM
    Oncogene; 2004 Feb; 23(5):1136-45. PubMed ID: 14647415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.